BRIDGE HCV Building Bridges to Reach People Who Inject Drugs with the Goal to Eliminate HCV

Stacey Trooskin, MD, PhD


This activity is jointly provided by Purdue University College of Pharmacy and Integritas Communications.


This CME/CE activity is supported by educational grants from Gilead Sciences, Inc. and Merck & Co., Inc.

This CME/CE activity is based on the slides and lectures presented in the 2017 BRIDGE HCV live meeting series in Philadelphia, PA.


Stacey Trooskin, MD, PhD
Director of Viral Hepatitis Programs
Jonathan Lax Treatment Center 
Philadelphia FIGHT 
Philadelphia, Pennsylvania

Target Audience

This activity was developed for hepatologists, gastroenterologists, infectious disease specialists, and other health care providers currently treating hepatitis C virus (HCV).

Goal Statement

The goals of this activity are to prepare community-based HCV treaters to provide effective therapy for HCV-positive people who inject drugs (PWID), to increase HCV testing and treatment of PWIDs through proactive risk identification and referral by addiction-services centers, and to educate HCV-care specialists and addiction-services personnel regarding harm-reduction principles and the prevention of HCV reinfection.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Demonstrate actionable knowledge of clinically applicable epidemiologic data on HCV-positive people who inject drugs (PWID) and HCV treatment rationale, principles, and goals pertinent to this population
  • Collaborate with addiction-services professionals to optimize referral of HCV-positive PWID, treatment outcomes, and prevention of posttreatment reinfection, thereby reducing the prevalence and incidence of HCV infection within the local service area
  • Prescribe the new, highly effective direct-acting antiviral (DAA)-drug regimens for treatment of HCV-positive PWID
  • Incorporate harm-reduction principles and practices across the HCV-care continuum

Accreditation Statements

ACCME: This activity has been planned and implemented in accordance with the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and Integritas Communications. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

ANCC: Purdue University Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ACPE: Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

Physician Credit Designation

Purdue University College of Pharmacy designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit Designation

This program has been approved for 0.75 contact hour.

Pharmacy Credit Designation

This is a knowledge-based, continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Activity Number (UAN): 0018-9999-17-087-H01-P; 0.75 Contact Hour, (0.075 CEU)

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Purdue University College of Pharmacy and Integritas Communications do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Faculty, Staff, and Reviewer Disclosure Statement

All faculty, staff, and reviewers involved in the planning, review, or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. 

The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME/CE activity: 

Stacey Trooskin, MD, PhD Advisor/Consultant: Gilead Sciences, Inc.; Clinical Research: Gilead Sciences, Inc.

All additional planning committee members, staff, and reviewers of Integritas Communications and Purdue University College of Pharmacy have no relationships to disclose.

Instructions to Receive Credit

In order to receive credit, participants must complete the pre-assessment questions, view the activity in its entirety, and the post-test, and program evaluation. Participants must also score at least 75% on the post-test. You will receive a digital copy of your credit certificate at the conclusion of the activity.  Pharmacist's ACPE credits will be uploaded to CPE Monitor within 45 days.

For information about the accreditation of this program, please contact Purdue at

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

System Requirements

Microsoft Windows 2000 SE or above.
Flash Player Plugin (v7.0.1.9 or greater)
Internet Explorer (v5.5 or greater), or Firefox
Adobe Acrobat Reader*

MAC OS 10.2.8
Flash Player Plugin (v7.0.1.9 or greater)
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh.

Copyright Statement

©2018 Purdue University College of Pharmacy and Integritas Communications.

Click "Begin Activity" to acknowledge that you have reviewed the preamble information for this activity.

Begin Activity

expiration 02/08/2019